VHL and cancer: Degrader activity profiling in relevant cancer cells supportedthe discovery of ACBI4, a PROTAC which forms a highly stable and cooperativeternary complex between VHL and GTP-bound KRAS and which potentlydegrades KRASG12R, leading to antiproliferative effectin KRAS mutant-driven cancer cells.